BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28825953)

  • 1. Chronic Airway Fibrosis in Orthotopic Mouse Lung Transplantation Models-An Experimental Reappraisal.
    Yamada Y; Windirsch K; Dubs L; Kenkel D; Jang JH; Inci I; Boss A; Martinu T; Vanaudenaerde B; Weder W; Jungraithmayr W
    Transplantation; 2018 Feb; 102(2):e49-e58. PubMed ID: 28825953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
    Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
    Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane preconditioning protects from posttransplant injury in mouse lung transplantation.
    Yamada Y; Laube I; Jang JH; Bonvini JM; Inci I; Weder W; Beck Schimmer B; Jungraithmayr W
    J Surg Res; 2017 Jun; 214():270-277. PubMed ID: 28624055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.
    Mimura T; Walker N; Aoki Y; Manning CM; Murdock BJ; Myers JL; Lagstein A; Osterholzer JJ; Lama VN
    Am J Pathol; 2015 Jun; 185(6):1564-74. PubMed ID: 25848843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
    Oishi H; Martinu T; Sato M; Matsuda Y; Hirayama S; Juvet SC; Guan Z; Saito T; Cypel M; Hwang DM; Keller TL; Whitman MR; Liu M; Keshavjee S
    J Heart Lung Transplant; 2016 Apr; 35(4):518-27. PubMed ID: 26787621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.
    Kuo E; Bharat A; Goers T; Chapman W; Yan L; Street T; Lu W; Walter M; Patterson A; Mohanakumar T
    Ann Thorac Surg; 2006 Sep; 82(3):1043-50. PubMed ID: 16928532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel reduces post-transplant obliterative bronchiolitis.
    Preidl RH; Eckl S; Ramsperger-Gleixner M; Koch N; Spriewald BM; Weyand M; Ensminger SM
    Transpl Int; 2013 Oct; 26(10):1038-48. PubMed ID: 23952051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis.
    KleinJan A; Willart MA; Kuipers H; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Transplantation; 2008 Nov; 86(10):1436-44. PubMed ID: 19034015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-short echo-time magnetic resonance imaging distinguishes ischemia/reperfusion injury from acute rejection in a mouse lung transplantation model.
    Chuck NC; Boss A; Wurnig MC; Weiger M; Yamada Y; Jungraithmayr W
    Transpl Int; 2016 Jan; 29(1):108-18. PubMed ID: 26339975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study.
    Heigl T; Kaes J; Aelbrecht C; Serré J; Yamada Y; Geudens V; Van Herck A; Vanstapel A; Sacreas A; Ordies S; Frick A; Saez Gimenez B; Van Slambrouck J; Beeckmans H; Acet Oztürk NA; Orlitova M; Vaneylen A; Claes S; Schols D; Vande Velde G; Schupp J; Kaminski N; Boesch M; Korf H; van der Merwe S; Dupont L; Vanoirbeek J; Godinas L; Van Raemdonck DE; Janssens W; Gayan-Ramirez G; Ceulemans LJ; McDonough JE; Verbeken EK; Vos R; Vanaudenaerde BM
    Front Immunol; 2024; 15():1369536. PubMed ID: 38736881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
    Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
    Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A relevant experimental model for human bronchiolitis obliterans syndrome.
    Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
    J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide-releasing molecule attenuates allograft airway rejection.
    Ohtsuka T; Kaseda K; Shigenobu T; Hato T; Kamiyama I; Goto T; Kohno M; Shimoda M
    Transpl Int; 2014 Jul; 27(7):741-7. PubMed ID: 24628975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26 as a target against fibrous formation in chronic airway rejection lesions.
    Jungraithmayr W; Yamada Y; Haberecker M; Breuer E; Schuurmans M; Dubs L; Itani S; Janker F; Weder W; Schmitt-Opitz I; Jang JH
    Life Sci; 2021 Aug; 278():119496. PubMed ID: 33894269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational research: animal models of obliterative bronchiolitis after lung transplantation.
    Sato M; Keshavjee S; Liu M
    Am J Transplant; 2009 Sep; 9(9):1981-7. PubMed ID: 19663891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.